Enhancing the Transition from Hospital to Home for Patients with Traumatic Brain Injury and Families

促进脑外伤患者及其家人从医院到家庭的过渡

基本信息

  • 批准号:
    9901803
  • 负责人:
  • 金额:
    $ 16.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-02-01 至 2022-01-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Despite high risks of readmission and complex medical needs, there are no transitional care standards in the U.S. for patients with moderate-to-severe traumatic brain injury (TBI). Patients with moderate-to-severe TBI (age < 65 years) discharged home from acute hospital care without inpatient rehabilitation have cognitive, physical, behavioral, and emotional impairments that affect their abilities to independently self-manage their health, wellness, and activities of daily living. Activity limitations often result in increased family involvement for managing the person’s care. The complexity of needs combined with the fragmentation of healthcare services creates the perfect storm for mismanaged symptoms, adverse health events, readmissions, and a lower likelihood of return to work and school. Transitional care is defined as actions in the clinical encounter designed to ensure the coordination and continuity of healthcare for patients transferring between different locations or levels of care in close geographic proximity. In other patient groups who experience acute events (e.g., stroke, myocardial infarction), transitional care management has led to improved patient and family outcomes. Although preliminary research shows that patients with TBI and families desire and could benefit from interventions to support the transition from acute hospital care to home, the strength of evidence on this topic is low. TBI transitional care interventions developed to date are ineffective in improving functional outcomes and do not incorporate family needs. Thus, the purpose of our study is to first develop and refine a patient- and family-centered TBI transitional care intervention to support patients with moderate-to-severe TBI and their family caregivers during the transition home from acute hospital care. The intervention will aim to improve functional status for patients with TBI, reduce strain for their family caregivers, and direct patients and families to appropriate resources and care that is concordant with their health-related goals. Second, we will examine the feasibility and acceptability and assess the preliminary efficacy of the TBI transitional care intervention. Our primary outcome will be patient functional status at 8 weeks post-discharge. We will also examine secondary outcomes at 8 weeks post-discharge, including family caregiver strain and preparedness for the caregiving role, and patient and family caregiver self-efficacy and healthcare utilization. The new knowledge generated from the proposed research will guide our research team in designing and conducting an NIH R01 implementation-effectiveness clinical trial of the TBI transitional care intervention and will ultimately enhance the standard of care for patients with TBI discharged home from acute hospital care and families.
摘要 尽管再入院的风险很高,医疗需求也很复杂,但美国没有过渡性护理标准。 美国对于中度至重度创伤性脑损伤(TBI)患者。中重度TBI患者 (age<65岁)从急性医院护理出院回家,没有住院康复, 身体,行为和情感障碍,影响他们独立自我管理的能力, 健康、保健和日常生活活动。活动限制往往导致家庭参与增加, 管理该人的护理。需求的复杂性加上医疗服务的分散性 为管理不当的症状、不良健康事件、再入院和较低的 返回工作和学校的可能性。过渡期护理的定义是在临床遇到的行动 旨在确保在不同地点之间转移的患者的医疗保健的协调和连续性 在地理上接近的地点或护理水平。在发生急性事件的其他患者组中 (e.g.,中风、心肌梗塞),过渡性护理管理已导致患者和家庭改善 结果。尽管初步研究表明,TBI患者及其家属希望并可能受益 从干预措施到支持从急性医院护理到家庭护理的过渡, 话题低。迄今为止开发的TBI过渡性护理干预措施在改善功能方面无效 结果并不包括家庭需求。因此,我们研究的目的是首先开发和完善一个 以患者和家庭为中心的TBI过渡性护理干预,为中重度TBI患者提供支持 和他们的家庭照顾者在从急性医院护理过渡回家期间。干预的目的是 改善TBI患者功能状态,减轻其家庭护理人员的压力,并指导患者, 家庭获得与其健康相关目标相一致的适当资源和护理。二是 检查TBI过渡护理的可行性和可接受性,并评估其初步疗效 干预我们的主要结局是患者出院后8周的功能状态。我们还将 检查出院后8周的次要结局,包括家庭照顾者的压力和准备情况 对于照顾者角色,以及患者和家庭照顾者自我效能和医疗保健利用。新 从拟议的研究中产生的知识将指导我们的研究团队设计和进行一项 NIH R01实施TBI过渡护理干预的有效性临床试验,并将最终 提高从急性医院护理出院回家的创伤性脑损伤患者及其家人的护理标准。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tolu O. Oyesanya其他文献

Testing of a Medication Management Course for Persons with Catastrophic Injuries and their Family Caregivers
  • DOI:
    10.1016/j.apmr.2018.07.319
  • 发表时间:
    2018-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Tolu O. Oyesanya;Tiffany Lecroy
  • 通讯作者:
    Tiffany Lecroy

Tolu O. Oyesanya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tolu O. Oyesanya', 18)}}的其他基金

A Randomized Controlled Trial of BETTER, A Transitional Care Intervention, for Diverse Patients with Traumatic Brain Injury and Their Families
BETTER(一种过渡性护理干预措施)针对不同脑外伤患者及其家人的随机对照试验
  • 批准号:
    10630498
  • 财政年份:
    2023
  • 资助金额:
    $ 16.36万
  • 项目类别:
Enhancing the Transition from Hospital to Home for Patients with Traumatic Brain Injury and Families
促进脑外伤患者及其家人从医院到家庭的过渡
  • 批准号:
    10089463
  • 财政年份:
    2020
  • 资助金额:
    $ 16.36万
  • 项目类别:
Inpatient Rehabilitation for Women with Traumatic Brain Injury and Their Families
脑外伤女性及其家人的住院康复
  • 批准号:
    9101813
  • 财政年份:
    2015
  • 资助金额:
    $ 16.36万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 16.36万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了